Mera Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2020	FY 2019	FY 2011	FY 2010	FY 2009	2008 - 2004
Period Ending	Feb '26 Feb 24, 2026	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019	Oct '11 Oct 31, 2011	Oct '10 Oct 31, 2010	Oct '09 Oct 31, 2009	2008 - 2004
Market Capitalization	0	0	0	1	2	3	Upgrade
Market Cap Growth	-99.99%	66.67%	-84.75%	-33.33%	-40.00%	7.33%	Upgrade
Enterprise Value	-	1	0	1	2	3	Upgrade
Last Close Price	0.00	0.00	0.00	0.00	0.00	0.01	Upgrade
PS Ratio	-	-	-	3.62	5.69	4.57	Upgrade
PB Ratio	-0.01	-9.35	-6.91	-1.27	-2.43	-19.69	Upgrade
P/OCF Ratio	-	-	-	-	192.09	-	Upgrade
EV/Sales Ratio	-	-	-	3.79	5.87	4.64	Upgrade
Debt / Equity Ratio	-	-	-	-0.35	-0.33	-0.37	Upgrade
Net Debt / Equity Ratio	-	-	-	-0.34	-0.33	-0.35	Upgrade
Net Debt / EBITDA Ratio	-	-	-	-1.53	-1.05	-0.42	Upgrade
Net Debt / FCF Ratio	-	-	-	-3.98	-1.56	-0.96	Upgrade
Asset Turnover	-	-	-	4.20	1.75	1.84	Upgrade
Quick Ratio	-	-	-	0.01	0.02	0.03	Upgrade
Current Ratio	-	-	-	0.06	0.02	0.07	Upgrade
Return on Assets (ROA)	-	-	-	-174.48%	-89.65%	-38.69%	Upgrade
Return on Capital Employed (ROCE)	26.60%	18.80%	23.10%	23.30%	35.10%	145.10%	Upgrade
Earnings Yield	-1915.08%	-2.00%	-3.34%	-17.13%	-32.73%	-7.04%	Upgrade
FCF Yield	-	-	-	-6.77%	-8.61%	-1.85%	Upgrade
Buyback Yield / Dilution	-1.83%	-	-1.74%	-	-0.09%	-5.89%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.